Style | Citing Format |
---|---|
MLA | Masoudifar R, et al.. "Nanotechnology-Based Theranostic Approaches in Brain Diseases." Theranostics Nanomaterials in Drug Delivery, vol. , no. , 2024, pp. 363-393. |
APA | Masoudifar R, Moezzi SMI, Shahrbabak SM, Ahmadi M, Hajihosseini S, Anvari Z, Saadati S, Pouyanfar N, Ghorbanibidkorpeh F (2024). Nanotechnology-Based Theranostic Approaches in Brain Diseases. Theranostics Nanomaterials in Drug Delivery, (), 363-393. |
Chicago | Masoudifar R, Moezzi SMI, Shahrbabak SM, Ahmadi M, Hajihosseini S, Anvari Z, Saadati S, Pouyanfar N, Ghorbanibidkorpeh F. "Nanotechnology-Based Theranostic Approaches in Brain Diseases." Theranostics Nanomaterials in Drug Delivery , no. (2024): 363-393. |
Harvard | Masoudifar R et al. (2024) 'Nanotechnology-Based Theranostic Approaches in Brain Diseases', Theranostics Nanomaterials in Drug Delivery, (), pp. 363-393. |
Vancouver | Masoudifar R, Moezzi SMI, Shahrbabak SM, Ahmadi M, Hajihosseini S, Anvari Z, et al.. Nanotechnology-Based Theranostic Approaches in Brain Diseases. Theranostics Nanomaterials in Drug Delivery. 2024;():363-393. |
BibTex | @article{ author = {Masoudifar R and Moezzi SMI and Shahrbabak SM and Ahmadi M and Hajihosseini S and Anvari Z and Saadati S and Pouyanfar N and Ghorbanibidkorpeh F}, title = {Nanotechnology-Based Theranostic Approaches in Brain Diseases}, journal = {Theranostics Nanomaterials in Drug Delivery}, volume = {}, number = {}, pages = {363-393}, year = {2024} } |
RIS | TY - JOUR AU - Masoudifar R AU - Moezzi SMI AU - Shahrbabak SM AU - Ahmadi M AU - Hajihosseini S AU - Anvari Z AU - Saadati S AU - Pouyanfar N AU - Ghorbanibidkorpeh F TI - Nanotechnology-Based Theranostic Approaches in Brain Diseases JO - Theranostics Nanomaterials in Drug Delivery VL - IS - SP - 363 EP - 393 PY - 2024 ER - |